SEE ALSO...
Items 1 to 10 of 14 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BU 224 hydrochloride | 187173-05-3 | sc-203857 sc-203857A | 10 mg 50 mg | $119.00 $495.00 | 1 | |
BU 224 hydrochloride functions as a nischarin, exhibiting selective binding to specific protein targets that modulate intracellular calcium levels. Its unique molecular architecture allows for the formation of hydrogen bonds, influencing conformational changes in target proteins. The compound's hydrophilic nature enhances its solubility in aqueous environments, promoting rapid distribution. Additionally, its kinetic profile reveals a propensity for reversible interactions, impacting its overall stability and reactivity in diverse chemical contexts. | ||||||
KU14R | 189224-48-4 | sc-204031 sc-204031A | 10 mg 50 mg | $141.00 $599.00 | 2 | |
KU14R acts as a nischarin, characterized by its ability to engage in specific non-covalent interactions with target biomolecules. Its unique structural features facilitate the formation of π-π stacking and hydrophobic interactions, which are crucial for its binding affinity. The compound demonstrates a distinctive reaction kinetics profile, exhibiting a rapid association and slower dissociation rate, thereby enhancing its effectiveness in modulating cellular pathways. Its amphiphilic nature contributes to its versatile behavior in various environments. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of PI3K, which is involved in the pathway that can affect Nischarin function related to cell migration and adhesion. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that can modulate the PI3K/Akt signaling pathway, influencing processes where Nischarin is implicated. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which acts upstream of ERK in the MAPK pathway, indirectly affecting Nischarin-associated pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which can alter the MAPK/ERK pathway and consequently influence Nischarin′s role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can regulate the PI3K/Akt/mTOR pathway, which is a potential regulator of Nischarin-mediated processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, can modulate the stress-activated MAPK pathway, affecting cellular functions associated with Nischarin. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which can impact the MAPK pathway, influencing cellular processes that involve Nischarin. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
An EGFR inhibitor that can affect downstream signaling pathways involving Nischarin. | ||||||